NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fiscal second quarter revenues rose 10 percent year over year, driven by breast health and international revenues.

For the three months ended March 31, the firm reported revenues of $789.3 million, up from $715.4 million a year ago, and beating the consensus Wall Street estimate of $781.8 million.